Prepare for your visit
Jeffrey A Hammoudeh
Plastic and Reconstructive Surgery · Los Angeles, CA · NPI 1285715086
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$159,422.68
in general payments reported to CMS, 2019-2025 · $90K in 2025
The $90K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Who reported paying
General payments only, top 6 by amount.
- Kls-Martin L.P. $158,742.74
- Stryker Corporation $454.59
- Allergan, INC. $95.75
- Zimvie INC. $47.16
- Depuy Synthes Sales INC. $45.93
- Straumann USA LLC $36.51
Drugs and devices associated with these payments
Cmf Ips Level One Cmf,Plate, Recon, Tlts, Str, 2.7 Mm Screw,20 Hole, 160 Mm, T=3.0 Mm,Cp Titanium,Qty:001 Ea Level One Cmf,Plate, Recon, Tlts, Angle To Angle, 2.7 Mm Screw,32 Hole, 227 Mm, T=3.0 Mm,Cp Titanium,Qty:001 Ea Level One Cmf,Plate, Recon, Tlts, Angle, Right, 2.7 Mm Screw,26 Hole, 193 Mm, T=3.0 Mm,Cp Titanium,Qty:001 Ea Level One Cmf,Plate, Recon, Tlts, Angle, Left, 2.7 Mm Screw,26 Hole, 193 Mm, T=3.0 Mm,Cp Titanium,Qty:001 Ea Level One Cmf,Plate, Recon, Tlts, Angle To Angle, 2.0-2.5 Mm Screw,32 Hole, 222 Mm, T=2.0 Mm,Cp Titanium,Qty:001 Ea Level One Cmf,Plate, Fracture, Tlts, Angle, 2.0-2.5 Mm Screw,8 Hole, T=1.5 Mm,Ti-6al-4v,Qty:001 Ea Level One Cmf,Plate, Fracture, Tlts, Angle, 2.0-2.5 Mm Screw,6 Hole, T=1.5 Mm,Ti-6al-4v,Qty:001 Ea Level One Cmf,Plate, Recon, Tlts, Angle, Right, 2.0-2.5 Mm Screw,26 Hole, 190 Mm, T=2.0 Mm,Cp Titanium,Qty:001 Ea Level One Cmf,Plate, Recon, Tlts, Angle, Left, 2.0-2.5 Mm Screw,26 Hole, 190 Mm, T=2.0 Mm,Cp Titanium,Qty:001 Ea Level One Cmf,Screw, Maxdrive, Tlts,2.7 X 13 Mm,Ti-6al-4v,Qty:001 Ea
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jeffrey Hammoudeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1167786/jeffrey-a-hammoudeh